
Nostics is a medical diagnostics startup that combines photonics and AI to rapidly identify pathogen signatures through real-time spectral analysis of living microorganisms. Their flagship product is a miniaturized optical biosensor platform that delivers lab-comparable, rapid infection diagnostics in less than 10 minutes at the point of need, without requiring lab skills. Powered by the world's first Large Spectral Foundation Model for Microbiology, Nostics enables personalized treatment decisions, antimicrobial stewardship, and improved disease monitoring. The company targets healthcare providers and decentralized settings, aiming to democratize diagnostics globally, especially in rural and low-income areas, to combat antimicrobial resistance and reduce healthcare costs. Nostics has received recognition including finalist status for AI Discovery Award, European Patent Office Young Innovator Prize, and has attracted notable advisors and leadership in medtech.

Nostics is a medical diagnostics startup that combines photonics and AI to rapidly identify pathogen signatures through real-time spectral analysis of living microorganisms. Their flagship product is a miniaturized optical biosensor platform that delivers lab-comparable, rapid infection diagnostics in less than 10 minutes at the point of need, without requiring lab skills. Powered by the world's first Large Spectral Foundation Model for Microbiology, Nostics enables personalized treatment decisions, antimicrobial stewardship, and improved disease monitoring. The company targets healthcare providers and decentralized settings, aiming to democratize diagnostics globally, especially in rural and low-income areas, to combat antimicrobial resistance and reduce healthcare costs. Nostics has received recognition including finalist status for AI Discovery Award, European Patent Office Young Innovator Prize, and has attracted notable advisors and leadership in medtech.